Back
Genprex Vs. Ensysce Biosciences Industry Stock Comparison
Sell
32
GNPX
Genprex
Last Price:
2.02
Seasonality Move:
48.72%
Buy
66
ENSC
Ensysce Biosciences
Last Price:
0.57
Seasonality Move:
-4.09%
Sell
32
Genprex (GNPX)
is a Sell
Is Genprex a Buy, Sell or Hold?
- The current Genprex [GNPX] share price is $2.15. The Score for GNPX is 32, which is 36% below its historic median score of 50, and infers higher risk than normal.
- GNPX is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
66
Ensysce Biosciences (ENSC)
is a Buy
Is Ensysce Biosciences a Buy, Sell or Hold?
- The current Ensysce Biosciences [ENSC] share price is $0.65. The Score for ENSC is 66, which is 32% above its historic median score of 50, and infers lower risk than normal.
- ENSC is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
GNPX Stock Price Chart
ENSC Stock Price Chart
What is Ensysce Biosciences's stock price today?
-
The Ensysce Biosciences share price today is $0.65
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ENSC is experiencing selling pressure, which indicates risk of future bearish movement.
GNPX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.49 | Buy |
| Relative Strength Index (14 RSI): | 59.12 | Buy |
| Chaikin Money Flow: | -1934034 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.12 - 2.18) | Buy |
| Bollinger Bands (100): | (0.48 - 2.08) | Buy |
ENSC Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.07 | Buy |
| Relative Strength Index (14 RSI): | 68.45 | Buy |
| Chaikin Money Flow: | -75872446 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.15 - 0.45) | Buy |
| Bollinger Bands (100): | (0.29 - 0.51) | Buy |
GNPX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 2.29 | Sell |
| 20-day SMA: | 1.35 | Buy |
| 50-day SMA: | 0.83 | Buy |
| 200-day SMA: | 2.59 | Sell |
| 8-day EMA: | 2.12 | Buy |
| 20-day EMA: | 1.61 | Buy |
| 50-day EMA: | 1.21 | Buy |
| 200-day EMA: | 4.57 | Sell |
ENSC Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.46 | Buy |
| 20-day SMA: | 0.31 | Buy |
| 50-day SMA: | 0.34 | Buy |
| 200-day SMA: | 0.61 | Buy |
| 8-day EMA: | 0.49 | Buy |
| 20-day EMA: | 0.38 | Buy |
| 50-day EMA: | 0.36 | Buy |
| 200-day EMA: | 2.75 | Sell |
Genprex Earnings Growth & GNPX Earnings Dates
- Analysts estimate an earnings increase this quarter of $2.25 per share, a decrease next quarter of $0.00 per share, an increase this year of $18.50 per share, and an increase next year of $3.37 per share.
Ensysce Biosciences Earnings Growth & ENSC Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.28 per share, a decrease next quarter of $0.00 per share, an increase this year of $17.95 per share, and an increase next year of $1.37 per share.
Genprex Technical Analysis
| Oct 21 | Oct 22 | Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | ||||||||||
| 21 | 22 | 23 | 24 | 25 | 28 | 29 | 30 | 31 | 01 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Ensysce Biosciences Technical Analysis
| Oct 21 | Oct 22 | Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | ||||||||||
| 21 | 22 | 23 | 24 | 25 | 28 | 29 | 30 | 31 | 01 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||